{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T20:38:21Z","timestamp":1786653501866,"version":"build-2736575974"},"reference-count":9,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Indian J Pharmacol"],"published-print":{"date-parts":[[2015]]},"DOI":"10.4103\/0253-7613.161276","type":"journal-article","created":{"date-parts":[[2015,7,21]],"date-time":"2015-07-21T05:15:05Z","timestamp":1437455705000},"page":"451","source":"Crossref","is-referenced-by-count":3,"title":["Pentazocine-induced contractures: Dilemma in management"],"prefix":"10.4103","volume":"47","author":[{"given":"Ganesh","family":"Yadav","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dileep","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anil","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"VP","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arpita","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"AjayKumar","family":"Verma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"key-10.4103\/0253-7613.161276-1","first-page":"1542","volume-title":"Unusual cutaneous manifestations of pentazocine addiction","author":"Schiff","year":"1977","journal-title":"JAMA"},{"key":"key-10.4103\/0253-7613.161276-2","first-page":"47","volume-title":"Skin manifestations of pentazocine abuse","author":"Palestine","year":"1980","journal-title":"J Am Acad Dermatol"},{"key":"key-10.4103\/0253-7613.161276-3","first-page":"975","volume-title":"Cutaneous and venous complications of pentazocine abuse","author":"Padilla","year":"1979","journal-title":"Arch Dermatol"},{"key":"key-10.4103\/0253-7613.161276-4","first-page":"361","volume-title":"Pentazocine-induced fibromyositis and contracture","author":"Das","year":"1999","journal-title":"Postgrad Med J"},{"key":"key-10.4103\/0253-7613.161276-5","first-page":"160","volume-title":"Calcific myofibrosis due to pentazocine abuse: A case report","author":"Goyal","year":"2008","journal-title":"J Med Case Rep"},{"key":"key-10.4103\/0253-7613.161276-6","unstructured":"The Use of the WHO-UMC System for Standardised Case Causality Assessment. Available from: http:\/\/www.who-umc.org\/Graphics\/24734.pdf. [Last accessed on 2015 Feb 21]."},{"key":"key-10.4103\/0253-7613.161276-7","first-page":"239","volume-title":"A method for estimating the probability of adverse drug reactions","author":"Naranjo","year":"1981","journal-title":"Clin Pharmacol Ther"},{"key":"key-10.4103\/0253-7613.161276-8","first-page":"274","volume-title":"Focal myopathy induced by chronic heroin injection is reversible","author":"Weber","year":"2000","journal-title":"Muscle Nerve"},{"key":"key-10.4103\/0253-7613.161276-9","first-page":"90","volume-title":"Local changes at the site of pentazocine injection","author":"Schlicher","year":"1971","journal-title":"Arch Dermatol"}],"container-title":["Indian Journal of Pharmacology"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T19:38:21Z","timestamp":1786649901000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/0253-7613.161276"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015]]},"references-count":9,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2015]]}},"alternative-id":["161276"],"URL":"https:\/\/doi.org\/10.4103\/0253-7613.161276","relation":{},"ISSN":["0253-7613"],"issn-type":[{"value":"0253-7613","type":"print"}],"subject":[],"published":{"date-parts":[[2015]]}}}